| Entry |
|
|---|
| Name |
HBV HBeAg to TLR2/4-NFKB signaling pathway
|
|---|
| Definition |
C -| MYD88 |
|---|
| Expanded |
K23129 -| 4615 |
|---|
| Class |
|
|---|
| Type |
Pathogen
|
|---|
| Pathway |
|
|---|
| Disease |
| H00048 | Hepatocellular carcinoma |
|
|---|
| Gene |
| 4615 | MYD88; MYD88, innate immune signal transduction adaptor |
|
|---|
| Perturbant |
| K23129 (C) | C; HBV capsid protein |
|
|---|
| Reference |
|
|---|
| Authors |
Ortega-Prieto AM, Dorner M |
|---|
| Title |
Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Bagheri V, Askari A, Arababadi MK, Kennedy D |
|---|
| Title |
Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection? |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Zhang E, Lu M |
|---|
| Title |
Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection. |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
